医疗保健政策和妇女的健康 : 主要文章列印這項條款给这项条款发电子邮件

ÈéÏÙ°©µÄÍâ¿Æ¹ÜÀíµÄÑݱä

ÁÙ´²ÐÅϢϵÁÐÔÚÈéÏÙ°©ÎªÒ½ÉúºÍÉçÇø, ÓÉWomen ¡¤µÄHealth ×¼±¸& ½ÌÓýÖÐÐÄ(WHEC) ¡£
ÌØ±ðÓÉÓÚ eclecTechs ËûÃǵÄÖ§³ÖºÍÓÑÒê¡£

ÈéÏÙ°©µÄÀúÊ··½ÃæµÄ¹ÅÀÏÎÄÏ׺ÍÏë·¨µÄ·¢Õ¹¹ØÓÚËüµÄÉúÎï, ²¡ÀíÉúÀíѧºÍ¸ÅÄî¶ÔºÏÀíµÄÖÎÁƱíÃ÷, ÕâÖÖ¼²²¡×ÜÊÇÎÒÃǽñÌìÖªµÀµÄÏà¶ÔµØ¹²Í¬ºÍ¾ç¶¾¸öÌå¡£µ±ÐÂÉúÕÜѧÆôʾºÍѧ»á±»´«²¥±é¼°Å·ÖÞÔÚµÚ15 ºÍ16 ÊÀ¼Í, ×îÖÕµ¼ÖÂÈéÏÙ°©ÖÎÁÆÏÖ´úʱ´úµÄÐí¶àÔ­Ôò±»¿ª·¢ÁË»ò±»ÔÙ·¢ÏÖÁË¡£1698 ÄêµÚÒ»Íâ¿Æ³¢ÊԵĵ±ÖÐÒ»¸öÔÊÐíÓúºÏÓɱ»ÇÐµÄÆ¤·ô±ßÔµµÄÖ±½ÓÁªºÏ¸úËæÈé·¿³·³ýÓÉ·¶¡¤der Mullen ¼Ç¼ÁË¡£±¾½ÜÃ÷¡¤ÏìÁå(1749-1806), Íâ¿ÆÒ½Éú¶Ô°®¶¡±¤»Ê¼ÒÒ½ÁÆËù, ²»½öÖ÷ÕÅÁ˸ù±¾²Ù×÷ΪËùÓÐÈé·¿Ö×Áö¶øÇÒÇ¿µ÷ÁËÔçÆÚµÄÕï¶ÏµÄÖØÒªÐÔ¡£ÕâЩÈé·¿°©µÄÖÎÁƵÄÔ­ÔòÒÀÈ»ÊDZê×¼ÔÚËÕ¸ñÀ¼ÎªÏ¸öÊÀ¼Í¡£

Õâ¸öÎļþµÄÄ¿µÄ½«¸øÒ½ÁƱ£½¡×¨¼Ò¸÷ÖÖ¸÷ÑùµÄÍâ¿ÆÖÎÁÆ¿ÉÀûÓô¦ÀíÈéÏÙ°©¡£¸÷ÖÖ¸÷ÑùµÄÏÖ´úÖÎÁÆÐÎʽ²¢ÇÒ±»Ì¸ÂÛ¡£Íâ¿ÆÒ½Éú³ÉΪÁË´¦ÀíÓÐÈé·¿°©²¡ÈËÒ»¸ö²»Í¬µÄ¶ÓµÄÕûÌ岿·Ö¡£Õâ¸ö¶Ó°üÀ¨Õï¶Ï·ÅÉä¿Æ×¨¼Ò¡¢·øÉ䰩֢ҽʦ¡¢Ò½Áư©Ö¢Ò½Ê¦, ºÍ²¡Àíѧר¼Ò¡£ÎÒÃǵĸÕÒãÄ¿µÄ±ØÐë×ܽ«´Ù½ø¸÷Ãûµ¥¶À»¼ÕßµÄ×î´óÐËȤ, ºÍ²»ÊÇÄÇЩÊÖÊõ¡¢·ÅÉäÁÆ·¨»ò»¯ÁÆ¡£

ÏÖ´úʱ´ú:

ÆÌƽµÀ·ΪÓÐЧµÄ²Ù×÷ΪÈé·¿°©µÄ¶þ·ÉÔ¾ÊÇÒ»°ãÂé×íµÄ·¢Ïֺͷ¢Õ¹ºÍ¼²²¡µÄ¶¾¾úÀíÂÛµÄantisepsis µÄ´«²¥ºÍÔ­Ôò¡£¹æ·¶»¯µÄ, ÓÐЧ, ºÍ¹ã·º±»½ÓÊܵIJÙ×÷µÄÑݱäΪÈé·¿°©µÄÖÎÁÆÈñ»¯ÁËÒÔŬÁ¦ÍþÁ®Stewart Halsted (1852-1922) ¡£Halsted ±»×öÔÚÕâ¸öÇøÓòÊÇÐØ¿Ú¼¡ÈâµÄÖ÷Òª¹±Ï×(³ýÕû¸öÈé·¿Ö®Íâ) ²¢ÇÒ¸½ÉÏ×éÖ¯µÄçÇÃÜÇå½à¶¨ÆÚ³·³ýËûµÄÖ§³Ö¡£Ëü×îºó³öÃû×÷Ϊ¸ù±¾Èé·¿³·³ý¡£×îÓÐЧµÄÐÎʽΪ²é³öÈé·¿°©ÒÔËü×îÔçÆÚµÄÐÎʽ, µ±ÖÎÁÆÐíŵÊÇ×î³É¹¦µÄ, ÓÐËüµÄÆðµãÔçÔÚ1913 Äê¡£¶Ômammograms µÄÔö³¤µÄÓÃ;ÔÚÃÀ¹úÔÚ80 Äê´úÆÚ¼äµ¼Ö¼á¹Ì±ä»¯ÔÚ¼¼ÊõÉÏÓÉÍâ¿ÆÒ½ÉúʹÓÃÕï¶ÏÈé·¿°©¡£±ê×¼¿ª·ÅÍâ¿ÆÇÐÆ¬¼ì²é·¨Äܲ»ÔÙÖ´ÐÐÔÚ½ø²½µØ¸üСºÍ·ÇÃ÷ÏÔËðº¦ÓÉmammograms ²é³ö¡£ÕëµØ·½»¯ÇÐÆ¬¼ì²é·¨Óë±ê±¾ÔìÓ°ÑݱäÈçͬ×ͬµÄ·½·¨µØ·½»¯ºÍ׼ȷµØ³éÑù²»Ã÷ÏÔµÄÈé·¿Ëðº¦ÓÉmammogram ²é³ö¡£

»ù±¾µÄȱµãÔÚÀíÂ۵ط½¼²²¡ÆðÔ´ÓÉÊÖÊõµ¥¶À×ÜûÓнáÊøÔÚÖÎÁƵÄÊÂʵѸËÙÏÔ¶ÁË, ²»¹ÜÔõÑù¹ã·º×ö·¨»ò¼°ÔçÕï¶Ï¡£ËäÈ»Éú´æÔÚ3 ÄêÊÇÒÔ¸ü¼ÓÔçÆÚµÄ¹æ³Ì, ¸ü³¤µÄºóÐøÏÔ¶µÄƽÎȵؼõÉÙ¶Ô¹À¼ÆµÄ¸ÄÉÆ¡£Ðí¶àÍâ¿ÆÒ½ÉúŬÁ¦À©´ó¸ù±¾Èé·¿³·³ýµÄ·¶Î§±íÃ÷ËûÃÇÌå»áËüµÄ²»Êʵ±×÷Ϊµ¥Ò»ÖÎÁÆÎªÈé·¿°©(1) ¡£Èé·¿°©µÄÍâ¿ÆÖÎÁÆÏÔȻȱµã´øÁìһЩ¿¼ÂÇʹÓýϲ»¹ã·ºµÄ¹æ³ÌÓëÆäËüÐÎʽһµÀÈÄË¡»¼Õß¶àÓàµÄ×éÖ¯Ëðʧ¡£·ÅÉäÖÎÁÆÊǵÚÒ»¶ÔÓ¦µÄÐÎʽµÄµ±ÖÐÒ»¸öÏòÈé·¿°©±»ÉêÇëΪÕâ¸öÄ¿µÄ¡£ÕâÒ»Ìõ¹²Í¬µÄÂÝÎÆ±»·¢ÏÖÔÚʵ¼ÊÉϹØÓÚÈé·¿°©µÄÍâ¿ÆÖÎÁƵÄËùÓÐ×î½üÑо¿ÖÐÊÇ, ÀàÐͺͳ̶ȵط½ºÍµØ·½ÖÎÁƲ»¼«´óµØÓ°ÏìÉú´æ¡£ÓÐÈéÏÙ°©²¡ÈËÓÐÔÚϵͳ´«²¥µÄһЩDZÁ¦´Ó×îÔçÆÚµÄ½×¶Î¼²²¡·¢Õ¹¡£×î¾Þ´óµÄŵÑÔΪÓÐЧµÄÖÎÁƱØÐëÒò´ËÔÚÔÚϵͳÖÎÁÆ¡£

ϸ°û¶¾ËصϝÁƱäµÃÆÕ±éÔÚ50 Äê´úÍíÆÚºÍºóÀ´³ÉΪϵͳÁÆ·¨¶¤ÊéÕë¸úËæÍâ¿ÆÖÎÁÆ,ºÍ×÷ΪÕâÑùչʾÁ˸üºÃµÄÉú´æ±ÈÊÖÊõµ¥¶À¡£Ç°½øÔÚ·Ö×ÓÉúÎïѧµ¼ÖÂÁËÔÚ"oncogenes µÄ" ·¢ÏÖÉÏ, Ìṩ»òÐí²Ù×÷¶ñÐÔ´óÁ¿µÄ¹ý³Ì»ú»áÕû¸öµØ·ÀÖ¹Ëü¡£²ÉÄÉÃâÒßÁÆ·¨ÊÇÆäËüϵͳÖÎÁƵÄÐÎʽ½éÈëlymphokine-interleukin-2 µÄÓ¦ÓöԻîÔ¾"Ð×ÊÖ" ÁܰÍϸ°ûÒÔanti-tumor »î¶¯¡£Íâ¿ÆÒ½ÉúµÄ½ÇÉ«ÑݱäÁ˶ÔËùÓÐÁÙ´²Õï¶ÏºÍ±£Ö¤ÏÔÈ»¼²²¡³·³ýÒÔ±ã×î´ó»¯·øÉäºÍϵͳÁÆ·¨µÄÓÐЧÂÊ¡£Î´À´½øÕ¹µÄ×ȻµÄÔ¤ÑÔ±ØÐëÀ´×Ô¹ýÈ¥µÄÒ»¸öÏÖʵ¿´·¨¡£

Èé·¿³·³ýµÄÒ»°ãÔ­Ôò:

µ÷²éÔ±µÄÖØ´ó¹±Ï×ΪÈéÏÙ°©¹ÜÀíÔÚ20 ÊÀ¼Í½¨Á¢½á¹ûʹ±£ÊصÄÍâ¿Æ¼¼ÊõÊǵÈЧµÄÓëÄÇЩ¸ù±¾·½·¨¹ØÓÚÕûÌåÉú´æ¡£Òò¶ø×ö·¨±»Íê³ÉºÍÕ¾µã½ÓÊÜ·øÉäΪ½×¶Î0, I, ºÍII ¼²²¡È¡¾öÓÚÖ÷Òª´óÁ¿µÄµØµãÔÚÈé·¿¡¢³öÏÖ»ò°©Ö¢µÄȱ·¦ÁíÍâµÄ×ªÒÆ, ÐÍ, ºÍÖ×ÁöµÄ³É³¤ÌØÕ÷(¼´, ÒýÉì¶ÔÐØ¿Úǽ±Ú¡¢Æ¤·ô, ºÍÁíÍâµÄ×ªÒÆ¼¡×éÖ¯) ¡£Ëðº¦ÔÚÈé·¿µÄ²àÏò·½ÃæÖ÷ÒªµØÅÅйͨ¹ý¸¨ÖúÁܰÍÇþµÀ¡£Ë÷ÒýÖ×Áö½éÉÜÔÚÕâ¸öµØµã¿ÉÄܱ»¸ù³ý´ÓÐØ¿Úǽ±ÚÓÉʹÓÃÐ޸ĹýµÄ¸ù±¾Èé·¿³·³ýÒÔÉÚ±øÁܰͽáÇÐÆ¬¼ì²é·¨(SLNB) ¡£ÕâÍâ¿ÆÊÖÊõ×÷Ϊ×ÜÈé·¿³·³ýÒÔÐØ¿Ú¼¡ÈâµÄ±£´æºÍ°üÀ¨¸½ÉÏÁܰͽáµÄ½âÆÊ¡£ÕâЩ²àÏòµØ±»°²ÖõÄÁöÒÔÕýÃæÅþÁÚÁܰͽá×ªÒÆÒ²Ðí×é֯ѧÉÏͬÄÚ²¿Èé·¿»òÁܰͽá×ªÒÆÁªÏµÔÚÒ»ÆðÔÚ¶à´ï25% µ½30% »¼Õß¡£·ÅÉäÖÎÁƺͻ¯ÁƱ»Ê¹ÓÃΪ"Ö×ÁöµÄÑÏÖØ" ½éÉÜ: °þƤ¶¨Ïñ, nodularity, ´óÓÚ20% ½á½âÆÊÁË×é֯ѧÉϰüº¬, ³¬¹ýÈý¸ö×é֯ѧÉϱ»½éÈëµÄ½á, ºÍÐØ¿Úǽ±ÚÖ×Áö¶¨Ïñ(2) ¡£

ÔÚÖÐÐı»¹Ì¶¨¶ÔÐØ¿Ú¼¡ÈâÕÐÅÆ»ò¸ß˵»ÑµÄ±»ÕÒ³öµÄËðº¦(ÓÅÔ½µØ±»ÕÒ³öµÄ) Ë𺦱»¹Ì¶¨¶ÔÕâ¸öÕÐÅÆÒ²Ðí±»ÖÎÁÆÒÔ¸ù±¾Èé·¿³·³ý»òÒÔ×éºÏµÄ¸ù±¾Èé·¿³·³ýºÍÖܱßÁܰͲ¢ÇÒÐØ¿Úǽ±Ú·øÕÕÇøÓòµ±Ã÷ÏԵĸ¨ÖúÁܰͽá×ªÒÆ¸üС±È2 cm ÊÇÏÔÈ»µÄ¡£ÕâЩÔÚÖÐÐı»°²ÖõÄË𺦹²Í¬µØmetastasize ͨ¹ýlymphatics ÄÇÆ½ÐÐneuro Ѫ¹ÜÀ¦°óµÄ·ÏßÖмä¶ÔÐØ¿Ú¼¡Èâ¡£°üº¬²àÏòÐØ¿ÚÉñ¾­ºÍinnervates ÐØ¿Ú¼¡ÈâµÄÕâÖмäneuro Ѫ¹ÜÀ¦°ó±»±£´æÔÚÐ޸ĹýµÄ¸ù±¾Èé·¿³·³ý±£Ö¤Ðؿڼ¡ÈâµÄ×÷ÓÃÔÚÈé·¿³·³ýÒÔºó¡£ÔÚ¸ù±¾Èé·¿³·³ý×ö·¨, Õâ¸öneuro Ѫ¹ÜÀ¦°ó¡¢°éÉúµÄlymphatics, ºÍareolar ×éÖ¯ÊÇÊÜ×ð¾´µÄen ÍÅÌåÒԱ걾Íê³ÉµØ·½¼²²¡µÄ³ä·ÖÍâ¿Æextirpation ¡£

ΪÖм䱻ÕÒ³öµÄÁö, Ö÷ÒªÁܰÍÅÅË®É豸ÊÇͨ¹ý×·ÁÔ¶ÔÁܰͽáÔÚipsilateral ÄÚ²¿Èé·¿´¬¸½½üµÄ·Ïß¡£ÕâЩÖмäËðº¦Ò²ÐíÍ¬×ªÒÆÁªÏµÔÚÒ»Æð¶ÔÄÚ²¿Èé·¿lymphatics ÔÚ10% µ½30% »¼ÕßÖС£²¡ÀíÐÔµØÕýÃæ¸¨Öú×ªÒÆ³öÏÖÓë°éÉúµÄÖмäËðº¦Éý¼¶ÕâÄÚ²¿Èé·¿×ªÒÆµÄ·¢Éúµ½´óÓÚ50% ¡£ÔÚûÓÐÁÙ´²ÕýÃæ¸¨Öú×ªÒÆÊ±, Öм䱻ÕÒ³öµÄ°©Ö¢Ò²Ðí³ä·ÖµØ±»ÖÎÁÆÒÔ·Öװʽ(²¿·Ý) Èé·¿³·³ý»òÒÔÐ޸ĹýµÄ¸ù±¾Èé·¿³·³ýºÍÖܱßÁܰͷøÕÕÇøÓò¡£

ÊÇ·ñÍâ¿ÆÒ½ÉúÑ¡Ôñ±£»¤»ò¸ù±¾·½·¨È¡¾öÓÚÖ×Áö´óСºÍÌØÕ÷¡¢Ò»°ãÒ½ÁÆ×´Ì¬¡¢ÄÍÐÄÑ¡Ôñ, ºÍÓûÍûÎªÖØ½¨¡£²»¹Ü»úеÈËÔ±×ö·¨±»Ñ¡Ôñ, ²¡ÀíÐÔµØ"×ÔÓÉ" ±ß¼ÊÇå³ý¹ØÓÚÁöÔÚÈý¸öά¶ÈÊÇÖÁ¸ßÎÞÉϵĶԵط½ºÍµØ·½ÎÞ¼²²¡Éú´æµÄ¸Ä½ø¡£Íâ¿ÆÒ½Éú, Ó¦¸Ã¼Æ»®ÓÐЧµÄ×ö·¨ÓëÖ÷¹Û´ïµ½, ÔÚ¼«Ð¡Öµ, 1-2 cm Ƥ·ô±ß¼ÊÒÔÆ¤·ôϺÍparenchymal ±ß¼Ê2 µ½3 cm ËÄÃæ°Ë·½´ÓË÷ÒýÖ×Áö, ¿ÉÄܱ»Íê³ÉÒÔ»ù´¡¡¢Ð޸ĹýµÄ»ù´¡, »ò±»À©´óµÄ¼òµ¥µÄÈé·¿³·³ý¡£ÓÐÒ£Ô¶µÄ×ªÒÆ²¡ÈË, °üÀ¨supraclavicular Áܰͽá×ªÒÆ, ×îºÃÖÎÁÆÒÔϵͳ»¯ÁÆÓлòûÓеط½ºÍµØ·½·øÕÕÇøÓò(3) ¡£

ÇпªÉè¼ÆÎªÈé·¿³·³ýÔÚÈé·¿¾ÞзÐÇ×ùµÄÖÎÁÆ:

ÖÐÑëºÍsubareolar Ö÷ÒªËðº¦- ¾­µäStewartÊ¡ÂÔÆ¤·ôÇпª±»Ê¹ÓÃΪÈé·¿³·³ý¡£Stewart ÇпªÓÉÕûÐÎÍâ¿ÆÒ½Éú¹²Í¬µØ¸üϲ»¶ÆÚÍû±»ÑÓ³ÙµÄÖØ½¨Óëmyocutaneous µ²Ë®°å, ÌØ±ðÊǵ±¶Ô²à¼òµ¥µÄÈé·¿³·³ý¶Ô¸ß·çÏÕ¼²²¡µÄÖÎÁƼƻ®»ò×÷Ϊһ¸öÔ¤·À¼²²¡µÄ×ö·¨¡£´ËÍâ, Õâ¸ö¼¼Êõ¾­³£ÊÇoncologic Íâ¿ÆÒ½ÉúÑ¡Ôñµ±·øÉä¶ÔÐØ¿Úǽ±Ú¼Æ»®ÔÚÖØ½¨Ö®Ç°¡£

Éϲ¿»ò¸üµÍµÄÄÚÔÚÏóÏÞËðº¦- ×îСµÄƤ·ô±ß¼Ê1 µ½2 cm ´ÓÖ÷ÒªÁö±»ºÏ²¢ÔÚÊÇÇá΢µØÇãб´ÓºáÏòÏßÒÔcephalad ÒýÉìÍùҸϵÄÐ޸ĹýµÄOrr Çпª¡£ÏàËÆÓëOrr ºÍStewart Çпª, ËäÈ»ÓÐЩ¸ü¼ÓÇãб, ÕâЩÇпª½è×Ô¼º¶ÔÓ뻯ױÓйصØÁîÈËÂúÒâµÄÈé·¿ÖØ½¨½á¹ûʹÓÃmyocutaneous»òsubpectoral Ôö¹ã·áÈéÊÖÊõ¡£

Éϲ¿ÄÚÔÚÏóÏÞËðº¦- ÄÑ´¦ÀíÓÉÓÚËûÃǵĽâÆÊµØµã¡£Íâ¿ÆÒ½ÉúÓ¦¸ÃÈϿɹÌÓÐÎÊÌâÓöµ½ÒÔµÄÆ¤·ôµ²Ë®°åº£°ÎÔÊÐí³ä·ÖÍâ¿Æ±ß¼ÊºÍΪ´´É˹رպÍDZÁ¦Öؽ¨Ìṩcosmesis ¡£Íâ¿ÆÒ½ÉúÓ¦¸ÃÄÜ¿ª·¢1 µ½2 cm ±ß¼ÊΪÊÇÔÚÕâ¸öÏóÏÞµÄËðº¦, ÌṩË𺦲»ÊÇcephalad (infraclavicular) ¡£ÕâЩËðº¦Ò²Ðí±»»ñȡͨ¹ýÐ޸ĹýµÄStewart Çпª¡£Íâ¿ÆÒ½ÉúÓ¦¸Ã¶ÔÓÅÔ½µ²Ë®°å¼Æ»®ÇпªµÄÍ·²¿²¿·ÝÕâÑù, ³ä·ÖͨÈë¶ÔÐØ¿Ú¼¡ÈâºÍ¶Ô¸¨ÖúÄÚÈݱ»±£Ö¤¡£

½µµÍÍâÃæÏóÏÞËðº¦- ÕâЩӦ¸ÃÓÐÇпªÉè¼ÆÏàËÆÓëÄÇЩÉϲ¿ÄÚÔÚÏóÏÞ, ÒԱ߼Ê1 µ½2 cmÔÚÖ÷ÒªË𺦸½½üºÍÒÔcephalad ±ß¼ÊµÄ×î´óÒýÉìÎªÐØ¿Ú¼¡ÈâºÍ¸¨ÖúÄÚÈݵĽâÆÊÌṩ´æÈ¡¶ÔÓÚµ²Ë®°å¡£

¸ß˵»ÑµÄ(infraclavicular) Ëðº¦- Óë´óËðº¦(T2, T3, T4) ÊǸß˵»Ñinfraclavicular, »ò¹Ì¶¨¶ÔÐØ¿Ú¼¡Èâ, Çпª±»Éè¼ÆÌṩһ×îС1 µ½2 cm ±ß¼Ê½«ÐèҪƤ·ô¼Þ½Ó覴ûò¸²¸ÇÃæÓëmyocutaneous µ²Ë®°å¡£Ô­Ê¼µÄHalsted ºÍÂõ¶ûÇпª, ÒÔËæºóÐÞ¸ÄÓÉGreenough, Ö÷ϯ, ºÍ»ÒÉ«Ö÷Òª±»Ê¹ÓÃΪT2, T3 Ö÷ÒªË𺦵ÄÖÎÁÆ, ºÍT4 ´óС¡£

Ƥ·ôÈÄË¡Èé·¿³·³ý:

ÓÐÏÞµÄÆ¤·ôÇгý¿ÉÄܱ»¶¨Òå×÷ΪÈéÍ·/Èé·¿Ôθ´ºÏÌ塢Ƥ·ôÔÚÇÐÆ¬¼ì²é·¨Õ¾µã¸½½ü, ºÍƤ·ôµÄÇгýÔÚ1 Ö®ÄÚµ½2 cm Ö×Áö±ß¼Ê¡£Õâ¸ö¼¼Êõͨ³£ÎþÉü5% µ½10% È鷿Ƥ·ô, »òÖ÷Òª½Ó½ü»ò±»¹Ø±ÕÓëÒ»¿é×ÔÉúµÄmyocutaneous µ²Ë®°å±»Ê¹ÓÃÌæ»»Èé·¿ÈÝÁ¿¡£¹·¶ú¶ä²»·¢ÉúÒÔÕâ¸ö¼¼Êõ, ÒòΪÓÐÏÞµÄÆ¤·ô³·³ý²»´´Ê¼Æ¤·ôÂÎËõÒԹرա£¿íƤ·ôÇгý¶¨ÆÚµØ±»Ê¹ÓÃÒÔÿ»ù´¡ºÍÐ޸ĹýµÄÈé·¿³·³ý¡£Èé·¿³·³ýÒÔ¿íÆ¤·ôÇгý¾­³£Êǰüº¬µÄÇгý³¬³ö30% µ½50% È鷿Ƥ·ô¡£Õⱻȥ³ý×÷ΪÍÖÔ², ÓÉ20 cm (³¤¶È) ͨ³£²âÁ¿10 cm (¿í¶È), ºÍÖ÷ÒªÊDZպϵġ£Ê¡ÂÔÇгý´Ù½øÈ¥³ýÓɹý·Ý×éÖ¯¿íƤ·ô³·³ýºÍËæºó½ôÕż¼ÊõÉÏ´´ÔìÔÚÖÕ¶ËÎÊÌâµÄƤ·ô¹Ø±ÕµÄ¹·¶ú¶ä¡£

ʵ¼ù±ê×¼Á¬ÐøµØÑݱäÈçÏÂ:

  1. È鷿Ƥ·ôµÄ×ÜÇгý, ¶Ô
  2. ¿íÇгýûÓÐÖ÷Òª¹Ø±Õ, ¶Ô
  3. ¿íÇгýÒÔÖ÷Òª¹Ø±Õ, ºÍ×îºó¶Ô
  4. "Ƥ·ôÈÄË¡×ÜÈé·¿³·³ý" ¡£

Ƥ·ôÈÄË¡µÄÈé·¿³·³ý±»Ê¹ÓÃÁËÖ÷ҪΪ»¼ÕßÓëAJCC - TNM ½×¶Î0, I, ºÍ¼°ÔçII ¼²²¡ÒªÇóÈé·¿³·³ýµ±ÓÐ×ÊñËÖ±½Ó×ÔÉúµÄÈé·¿ÖØ½¨(4) ¡£ÕâÊÇÕ÷Õ×ΪƤ·ôÈÄË¡µÄ¼¼ÊõÊǵÄÒ»°ã¹«ÖÚÓßÂÛ:

  1. ¼²²¡(ductal Ô­µØ, ÈκÎÂûÑÓÐÔ×é֯ѧ) Multicentricity
  2. ÂûÑÓÐÔ°©ÁªÏµÁËÊÇ25% ¸ü¶àÖ×ÁöÈÝÁ¿µÄÒ»¸ö¹ã·ºµÄIntraductal ×é·Ö
  3. T2 Ö×Áö(2 µ½5 cm), ÌØ±ðÊÇÄÇЩÒÔÎ¥¿¹¶ÔºóÐø¿¼ÊÔµÄÐÅÐĵIJ»ÔÞͬµÄÌØµãÔÚ·ùÉäÏßÕÕÏà»òÌå¸ñ¼ì²éÖÐ
  4. »áÒªÇóÈéÍ·Èé·¿Ôθ´ºÏÌåµÄ³·³ýµÄÒ»¸öÖÐÑëÖ×Áö
  5. Ô­µØ°©Ö¢Ð¡Ò¶Æ¬ºÍductal ÆðÔ´
  6. Multifocal, ×îСµÄÈéÏÙ°©(T mic. ¡¢T1a, T1b)
  7. ËùÓÐT1 ºÍ¿ÉÄÜT2.a - Ö×ÁöÉîÉîÔÚÈé·¿ÈáĤ×éÖ¯, Ëæºó¶øÀ´µÄneoadjuvant ÁÆ·¨Ö®ÄÚ, ÓëÖ×ÁöÈÝÁ¿µÄÖØ´ócytoreduction
  8. ÕýÃæ¼ÒÊ·(Ò»¼¶ÇׯÝ) »ò»ùÒòÉϱ»Ö¤ÊµµÄoncogenes mutagenesis (¼´, BRCA1, BRCA2) ÓëÁîÈË·³ÄÕµÄhistologic ÌØµãÒ»ÆðÆ©Èç·ÇµäÐÍСҶƬ»òductal ÔöÉú
  9. »¼ÕßÒÔºÍûÓÐfamilial ¿É¼Ì³ÐµÄ(»ùÒò) ¼²²¡µ±ÎïÀí»ò·ùÉäÏßÕÕÏàµÄÌØµã, »òÁ½¸ö, ¶ÔºóÐø¿¼ÊÔµÄÎ¥¿¹ÐÅÐÄ, ÌØ±ðÊǵ±¶à¸öÇÐÆ¬¼ì²é·¨±»±íÃ÷

ÒòËØÓ°ÏìÖ±½Ó±»ÑӳٵĸÚλÈé·¿³·³ýÖØ½¨:

ѸËÙǰ½øÔÚ¶ÔÈéÏÙ°©ÔÚ20 ºÍ¼°Ôç21 ÊÀ¼Í¸ù±¾ÉúÎïµÄÀí½â, Óëǰ½øÒ»ÆðÔÚÍâ¿Æ¼¼Êõ¸úËæ³öÏÖºÍÓ¦ÓÃvascularized myocutaneous µ²Ë®°å(µç³µºÍlatissimus), ÎªÖØ½¨ÌṩÁË¿ÉÐÐÑ¡ÔñÔÚÈé·¿³·³ýÒÔºó¡£Èé·¿ÖØ½¨Ö´ÐиÄÕý½âÆÊ·´³£ÐÔ, ²¢ÇÒÒò´Ë, ÕâÊÇÒ»¸ö¹¦ÄÜ×ö·¨¡£Èé·¿ÖØ½¨µÄ¶¨ÆÚ¿¼ÂÇÔÚÈé·¿³·³ý֮ʱ¿ÉÄÜ¿ÆÑ§µØÏÖÔÚ±»±£ÎÀΪÓн׶β¡ÈË0, I, ºÍIIa ¡£Õâ¸ö×Ó¼¯»¼ÕßÃèÊö³¬¹ýµ±Ç°½øÐÐÈé·¿³·³ýµÄ70% »¼Õß¡£ÒòΪÈé·¿ÖØ½¨°²È«±»Õ¹Ê¾ÁËÔÚ×ÐϸµÄÑо¿ÖÐ, Óв»Ã»ÓÐÆäËûÔ­Òò·ñÈÏÈéÏÙ°©»¼ÕßÖØ½¨±ÈÓзñÈÏËùÓÐÆäËü°©Ö¢»¼ÕßÖØ½¨¡£Ã»ÓÐÊý¾Ý½¨Òé, Ö±½ÓÖØ½¨¸ÉÉæÍâ¿ÆÖÎÁÆÓÉ»ò´«²¥°©Ö¢, Ñڲصط½ÔÙÏÖ, »òÓꦵØÓ°ÏìÉú´æ¡£ËüÏÖÔÚ±»ÈÏ¿É, ËùÓеط½ÔÙÏÖ¸ù±¾ÉÏÊÇϵͳ¼²²¡harbingers ²¢ÇÒÔÙÏÖ¿ÉÄÜ´æÔÚÖ»ÔÚÈé·¿×éÖ¯Ö®ÄÚ¡£Î¨Ò»µÄ²ÐÓàµÄÈé·¿×éÖ¯¸úËæÈé·¿³·³ýÊÇ»òÔÚÈ鷿Ƥ·ô»òÔÚδ±»È¥³ýÒÔÈé·¿³·³ýµÄÈé·¿×éÖ¯¡£ÔÚÖØ½¨ÒÔºó, ʲô»áÊÇÐØ¿Úǽ±ÚÔÙÏÖ³ÉΪƤ·ôÔÙÏÖ, Ö»ÓÐÒòΪƤ·ôÍêÈ«±»·ÖÀë´ÓÐØ¿Úǽ±ÚÓÉÖØ½¨¡£ÔÙÏÖ´Óδ¿´ÔÚÒ»¿é×ÔÉúµÄµ²Ë®°åµÄÎïÖÊÖ®ÄÚ, ÒòΪµ²Ë®°åµÄÓÍÖ¬ºÍ¼¡ÈâÊDz»ºÃ¿ÍµÄ¶ÔÈéÏÙ°©(5) µÄÒÆÖ²¡£

ËäÈ»¶ÔµØ·½ÔÙÏÖ»òÉú´æµÄDZÔÚµÄÓꦵÄ×÷ÓÃδʵÏÖ, ÄÇÀïÓ¦¸ÃÊǶÔÈé·¿ÖØ½¨µÄ×÷ÓõĹØÐÄÔÚ¸¨Ò©ÁÆ·¨¡£ËüÉúÎïÖØÒª¿ªÊ¼»¯ÁÆ28 µ½40 ÔÚÌìÄÚµÄextirpative ÁÆ·¨, Òò´ËÖØ½¨±ØÐëÖ÷Òª±»ÓúºÏÔÚµÚÒ»ÔÂÆÚ¼ä¡£»¯ÁÆ¿ÉÄÜ¿ªÊ¼µ±ÈÔÈ»ÓÐûÓÐepithelialized, µ«ÊÇËüÎÞ·¨¿ªÊ¼ÔÚ»µËÀµÄ×éÖ¯¡¢seromas, »ò´«È¾ÃæÇ°µÄÒ»¸ö±íÃæ´´ÉË¡£µ±ËüÊÂÏÈΪÈËËùÖª»¼Õß½«½ÓÊÜ»¯ÁÆ,ÖØ½¨Ñ¡ÔñÓ¦¸Ã°üÀ¨Î¨Ò»ÊǺõÄvascularized µÄµ²Ë®°å²¢ÇÒÖªµÀÓúºÏÖ÷Òª×÷ΪµÚһѡÔñ¡£Ö²Èë¹Ü¿ÉÄܱ»Ê¹ÓÃ, µ«Èç¹ûÖ²Èë¹ÜÓÐÓÐseroma»ò´«È¾µÄÎÊÌâ, ËüÒ²ÐíÊDZØÒªÈ¥³ýÖ²Èë¹Ü¸ÄÕýÒ½ÖÎÓõÄÎÊÌâºÍÔÊÐí»¯Áƽø²½¡£µ±·øÉ伯»®, ×éÖ¯À©Õ¹Æ÷ºÍÖ²Èë¹ÜÖØ½¨²»Ó¦¸Ã±»Ê¹ÓÃ, ÒòΪÁîÈ˲»ÂúµÄ¸ÕÓ²ÊDz»¿É±ÜÃâµÄµ±Ö²Èë¹Ü·ÅÈÈ¡£Î¨Ò»×ÔÉúµÄµ²Ë®°åÌṩÁîÈËÂúÒâµÄ½â´ðÔÚÕâЩ»¼Õß, ²¢ÇÒËüÊǸüºÃÍê³ÉÖØ½¨ÔÚÈé·¿³·³ý֮ʱ¡£

·øÉäͨ³£½øÐÐÒòΪÖ×ÁöÇгýÊõ±ß¼ÊÔÚÐØ¿Úǽ±Ú±»»³ÒÉ»òÒòΪÖ×ÁöÊÇ´óºÍ½øÈ¡µÄ¡£ÎÞÂÛÈçºÎ, Ö×ÁöÔÙÏÖµÄÔ­Òò»ò´ÖÁÓµÄÄÍÐÄÉú´æÊǼ²²¡, ²»ÊÇÖØ½¨µÄ½×¶Î¡£ÊÇ·ñÖ±½ÓÖØ½¨Ó¦¸ÃÖ´Ðиù±¾ÔÚ½×¶ÎIIb ºÍIII ÊǸü¶àÒ»¸öÉç»á¾ö¶¨±ÈÒ»¸öÒ½Áƾö¶¨¡£Éú´æÔÚÕâЩ»¼Õß²»»áÊÇÏóÄÇÒ»ÑùÔÚ¶àÊý»¼Õß, µ«ÊÇËüÓÉ×ÔÉúµÄÖØ½¨²»»áÓ°Ïì¡£

×ܽá:

¼°ÔçÔÚ20 ÊÀ¼Í, Íâ¿ÆÒ½ÉúÊǵ¥¶ÀÔڳе£¶ÔÈéÏÙ°©ÖÎÁƵÄÔðÈÎ, µ±Î¨Ò»µÄÖÎÁÆÊǸù±¾Èé·¿³·³ý¡£½ñÌì, ÓÐÖ§³Ö´Ó¼¸¸öѧ¿Æ, ²¢ÇÒÍâ¿Æ°©Ö¢Ò½Ê¦Ó¦¸ÃÊÇÕⱻЭµ÷µÄŬÁ¦Áìµ¼¡£°ïÖú»¼ÕßÑ¡ÔñÔÚÕâЩÀÏÁ·ÖÎÁÆÑ¡ÔñÖ®ÖÐÒªÇóÍâ¿Æ°©Ö¢Ò½Ê¦ºÍÖØ½¨Íâ¿ÆÒ½ÉúµÄŬÁ¦ºÍÏ໥ºÏ×÷¡£Ã»Ìå»áÊÀ´ú¼°ÔçµÄµ±´úÖ×Áöѧʵ¼ùÔÚ½×¶ÎII/ III ÒÔǰÒýµ¼ÁÙ´²ÊÔÑéÖ¸»Ó¶ÔÈéÏÙ°©ÖÎÁƵÄÎÒÃǵÄÀí½âÔÊÐí»¯ÁƵÄÐÂ×éºÏ, ÖØ½¨, ºÍ·øÉä¡£

²Î¿¼:

  1. Recht A, Houlihan MJ. Axillary lymph nodes and breast cancer: a review. Cancer 76:1491; 1995.
  2. Kuerer HM, Krishnamurthy S, Kronowitz SJ. Important technical considerations for skin-sparing mastectomy with sentinel lymph node dissection. Arch surg 137:747; 2002.
  3. Skoll PJ, Hudson DA. Skin-sparing mastectomy using a modified Wise pattern. Plast. Reconstr. Surg. 110:214; 2002.
  4. Kroll SS et al. The oncologic risks of skin preservation at mastectomy when combined with immediate reconstruction of the breast. Surg. Gynecol. Obstet. 172:17; 1991
  5. Losken A et al. Trends in unilateral breast reconstruction and management of the contralateral breast: the Emory Experience. Plast. Reconstr. Surg. 110:89; 2002
Women's Health & Education Center
Hospital Campus Medical Building
300 Stafford Street #265
Springfield, MA 01104
United States of America
Tel: 413-733-1177
www.womenshealthsection.com